Nova Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Nova Financial's RARE Position: Q3 2026 in Review
Nova Financial opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 160 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #737 among its holdings.
263 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Nova Financial held 160 shares of Ultragenyx Pharmaceutical worth $2.4K as of Q3 2026.
- Ultragenyx Pharmaceutical was a new Nova Financial position in Q3 2026.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #737 holding.
- 263 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.